ACCESS BIO, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,850 KRW | -2.28% |
|
-1.30% | -23.63% |
| 2023 | Access Bio, Inc. acquired an unknown minority stake in CuraPatient Inc. | CI |
| 2023 | Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACCESS BIO, INC. | Diagnostic & Testing Substances | -2.28% | -1.30% | -23.63% | -25.46% | +86.39% | 167M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- A950130 Stock
- Charts Access Bio, Inc.
- Comparison Chart
